The Business Research Company’s Chemotherapy-Induced Anemia Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Chemotherapy-Induced Anemia Global Market Report 2023 evaluates chemotherapy-induced anemia market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12513&type=smp
T The global chemotherapy-induced anemia market is expected to grow from $2.21 billion in 2022 to $2.40 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chemotherapy-induced anemia market is expected to reach $3.2 billion in 2027 at a CAGR of 7.6%.
The high prevalence of cancer and anemia is expected to propel the growth of the chemotherapy-induced anemia market going forward. Cancer is a disease where somebody’s cells grow out of control and spread to other body regions. In cancer patients receiving aggressive chemotherapy, whether with or without radiation therapy, cancer and chemotherapy-induced anemia (CIA) are frequent occurrences. The medication stimulates the production of red blood cells in the bone marrow and can be used to treat chemotherapy-induced anemia. For instance, in 2023, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence of head and neck cancer in the UK is projected to rise by 3% between 2023 and 2025, while deaths due to head and neck cancers are expected to increase by 12% between 2023 and 2025. Therefore, the high prevalence of cancer and anemia drives the growth of the chemotherapy-induced anemia market.
Get More Information On The Chemotherapy-Induced Anemia Market Report:
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
The chemotherapy-induced anemia market segments in the report are:
1) By Anemia: Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia
2) By Treatment Type: RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Multispecialty Clinics, Cancer Research Centers,Cancer Rehabilitation Centers
The table of contents in TBRC’s chemotherapy-induced anemia market report includes:
- Executive Summary
- Chemotherapy-Induced Anemia Market Characteristics
- Chemotherapy-Induced Anemia Market Trends And Strategies
- Chemotherapy-Induced Anemia Market – Macro Economic Scenario
5.1. Global Chemotherapy-Induced Anemia Historic Market Size and Growth, 2017 – 2022, Value ($ Billion)
- Chemotherapy-Induced Anemia Market Segmentation
- Chemotherapy-Induced Anemia Market Regional And Country Analysis
.
.
.
- Brazil Chemotherapy-Induced Anemia Market
- Middle East Chemotherapy-Induced Anemia Market
- Africa Chemotherapy-Induced Anemia Market
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
